500 related articles for article (PubMed ID: 24384736)
1. Exome sequencing greatly expedites the progressive research of Mendelian diseases.
Zhang X
Front Med; 2014 Mar; 8(1):42-57. PubMed ID: 24384736
[TBL] [Abstract][Full Text] [Related]
2. Discovery of mutations for Mendelian disorders.
Alkuraya FS
Hum Genet; 2016 Jun; 135(6):615-23. PubMed ID: 27068822
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing: impact of exome sequencing in characterizing Mendelian disorders.
Rabbani B; Mahdieh N; Hosomichi K; Nakaoka H; Inoue I
J Hum Genet; 2012 Oct; 57(10):621-32. PubMed ID: 22832387
[TBL] [Abstract][Full Text] [Related]
4. Revisiting Mendelian disorders through exome sequencing.
Ku CS; Naidoo N; Pawitan Y
Hum Genet; 2011 Apr; 129(4):351-70. PubMed ID: 21331778
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
6. Exome sequencing as a tool for Mendelian disease gene discovery.
Bamshad MJ; Ng SB; Bigham AW; Tabor HK; Emond MJ; Nickerson DA; Shendure J
Nat Rev Genet; 2011 Sep; 12(11):745-55. PubMed ID: 21946919
[TBL] [Abstract][Full Text] [Related]
7. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
[TBL] [Abstract][Full Text] [Related]
8. Statistical guidance for experimental design and data analysis of mutation detection in rare monogenic mendelian diseases by exome sequencing.
Zhi D; Chen R
PLoS One; 2012; 7(2):e31358. PubMed ID: 22348076
[TBL] [Abstract][Full Text] [Related]
9. An automatic and efficient pipeline for disease gene identification through utilizing family-based sequencing data.
Song D; Li N; Liao L
Biomed Mater Eng; 2015; 26 Suppl 1():S1797-803. PubMed ID: 26405949
[TBL] [Abstract][Full Text] [Related]
10. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
[TBL] [Abstract][Full Text] [Related]
11. Phenolyzer: phenotype-based prioritization of candidate genes for human diseases.
Yang H; Robinson PN; Wang K
Nat Methods; 2015 Sep; 12(9):841-3. PubMed ID: 26192085
[TBL] [Abstract][Full Text] [Related]
12. Exome and genome sequencing for inborn errors of immunity.
Meyts I; Bosch B; Bolze A; Boisson B; Itan Y; Belkadi A; Pedergnana V; Moens L; Picard C; Cobat A; Bossuyt X; Abel L; Casanova JL
J Allergy Clin Immunol; 2016 Oct; 138(4):957-969. PubMed ID: 27720020
[TBL] [Abstract][Full Text] [Related]
13. [Exome sequencing: an efficient strategy for identifying the causative genes of monogenic disorders].
Rebiya N; Patamu M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Oct; 28(5):525-7. PubMed ID: 21983726
[TBL] [Abstract][Full Text] [Related]
14. Massively Parallel Sequencing for Rare Genetic Disorders: Potential and Pitfalls.
McInerney-Leo AM; Duncan EL
Front Endocrinol (Lausanne); 2020; 11():628946. PubMed ID: 33679611
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases.
Saudi Mendeliome Group
Genome Biol; 2015 Jun; 16(1):134. PubMed ID: 26112015
[TBL] [Abstract][Full Text] [Related]
16. Utility of whole-exome sequencing for those near the end of the diagnostic odyssey: time to address gaps in care.
Sawyer SL; Hartley T; Dyment DA; Beaulieu CL; Schwartzentruber J; Smith A; Bedford HM; Bernard G; Bernier FP; Brais B; Bulman DE; Warman Chardon J; Chitayat D; Deladoëy J; Fernandez BA; Frosk P; Geraghty MT; Gerull B; Gibson W; Gow RM; Graham GE; Green JS; Heon E; Horvath G; Innes AM; Jabado N; Kim RH; Koenekoop RK; Khan A; Lehmann OJ; Mendoza-Londono R; Michaud JL; Nikkel SM; Penney LS; Polychronakos C; Richer J; Rouleau GA; Samuels ME; Siu VM; Suchowersky O; Tarnopolsky MA; Yoon G; Zahir FR; ; ; Majewski J; Boycott KM
Clin Genet; 2016 Mar; 89(3):275-84. PubMed ID: 26283276
[TBL] [Abstract][Full Text] [Related]
17. A Genocentric Approach to Discovery of Mendelian Disorders.
Hansen AW; Murugan M; Li H; Khayat MM; Wang L; Rosenfeld J; Andrews BK; Jhangiani SN; Coban Akdemir ZH; Sedlazeck FJ; Ashley-Koch AE; Liu P; Muzny DM; ; Davis EE; Katsanis N; Sabo A; Posey JE; Yang Y; Wangler MF; Eng CM; Sutton VR; Lupski JR; Boerwinkle E; Gibbs RA
Am J Hum Genet; 2019 Nov; 105(5):974-986. PubMed ID: 31668702
[TBL] [Abstract][Full Text] [Related]
18. The Rise and Rise of Exome Sequencing.
Ku CS; Cooper DN; Patrinos GP
Public Health Genomics; 2016; 19(6):315-324. PubMed ID: 27898412
[TBL] [Abstract][Full Text] [Related]
19. Disease gene identification strategies for exome sequencing.
Gilissen C; Hoischen A; Brunner HG; Veltman JA
Eur J Hum Genet; 2012 May; 20(5):490-7. PubMed ID: 22258526
[TBL] [Abstract][Full Text] [Related]
20. Use of whole exome and genome sequencing in the identification of genetic causes of primary immunodeficiencies.
Chou J; Ohsumi TK; Geha RS
Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):623-8. PubMed ID: 23095910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
